Consulting communities on feedback of genetic findings in international health research: sharing sickle cell disease and carrier information in coastal Kenya
Tóm tắt
International health research in malaria-endemic settings may include screening for sickle cell disease, given the relationship between this important genetic condition and resistance to malaria, generating questions about whether and how findings should be disclosed. The literature on disclosing genetic findings in the context of research highlights the role of community consultation in understanding and balancing ethically important issues from participants’ perspectives, including social forms of benefit and harm, and the influence of access to care. To inform research practice locally, and contribute to policy more widely, this study aimed to explore the views of local residents in Kilifi County in coastal Kenya on how researchers should manage study-generated information on sickle cell disease and carrier status. Between June 2010 and July 2011, we consulted 62 purposively selected Kilifi residents on how researchers should manage study-generated sickle cell disease findings. Methods drew on a series of deliberative informed small group discussions. Data were analysed thematically, using charts, to describe participants’ perceptions of the importance of disclosing findings, including reasoning, difference and underlying values. Themes were derived from the underlying research questions and from issues emerging from discussions. Data interpretation drew on relevant areas of social science and bioethics literature. Perceived health and social benefits generated strong support for disclosing findings on sickle cell disease, but the balance of social benefits and harms was less clear for sickle cell trait. Many forms of health and social benefits and harms of information-sharing were identified, with important underlying values related to family interests and the importance of openness. The influence of micro and macro level contextual features and prioritization of values led to marked diversity of opinion. The approach demonstrates a high ethical importance in many malaria endemic low-to-middle income country settings of disclosing sickle cell disease findings generated during research, alongside provision of effective care and locally-informed counselling. Since these services are central to the benefits of disclosure, health researchers whose studies include screening for sickle cell disease should actively promote the development of health policy and services for this condition in situations of unmet need, including through the prior development of collaborative partnerships with government health managers and providers. Community consultation can importantly enrich ethical debate on research practice where in-depth exploration of informed views and the potential for difference are taken into account.
Tài liệu tham khảo
Piel FB: Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013, 381 (9861): 142-151. 10.1016/S0140-6736(12)61229-X.
Weatherall DJ: Inherited Disorders of Hemoglobin. Disease Control Priorities in Developing Countries. Edited by: Jamison DT. 2006, Oxford: Oxford University Press, 663-680.
Rees DC, Williams TN, Gladwin MT: Sickle-cell disease. Lancet. 2010, 376 (9757): 2018-2031. 10.1016/S0140-6736(10)61029-X.
Weatherall DJ, Clegg JB: Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001, 79 (8): 704-712.
WHO: Genomics and World Health: Report of the Advisory Committee on Heath Research. 2002, Geneva: World Health Organization
Telfer P: Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica. 2007, 92 (7): 905-912. 10.3324/haematol.10937.
Grosse SD: The Jamaican historical experience of the impact of educational interventions on sickle cell disease child mortality. Am J Prev Med. 2012, 42 (6): e101-e103.
Makani J, Williams TN, Marsh K: Sickle cell disease in Africa: burden and research priorities. Ann Trop Med Parasitol. 2007, 101 (1): 3-14. 10.1179/136485907X154638.
Ohene-Frempong K: Newborn screening for Sickle Cell Disease in Ghana 2005. 2005, [cited 2011; Available from: http://www.ghanaweb.com/GhanaHomePage/NewsArchive/artikel.php?ID=76368, 2
Fullwiley D: Biosocial suffering:Order and illness in urban West Africa. BioSocieties. 2006, 1: 421-438. 10.1017/S1745855206004042.
WHO: Medical genetic services in developing countries: The ethical, legal and social implications of genetic testing and screening. 2006, Geneva: World Health Organization
Ravitsky V, Wilfond BS: Disclosing individual genetic results to research participants. Am J Bioeth. 2006, 6 (6): 8-17. 10.1080/15265160600934772.
Knoppers BM: The emergence of an ethical duty to disclose genetic research results: international perspectives. Eur J Hum Genet. 2006, 14 (11): 1170-1178. 10.1038/sj.ejhg.5201690.
Miller FA, Robert JS, Hayeems RZ: Questioning the consensus: managing carrier status results generated by newborn screening. Am J Public Health. 2009, 99 (2): 210-215. 10.2105/AJPH.2008.136614.
Sharp RR, Foster MW: Clinical utility and full disclosure of genetic results to research participants. Am J Bioeth. 2006, 6 (6): 42-44. 10.1080/15265160600938443. author reply W10-2
Miller FA: The complex promise of newborn screening. Indian Journal of Medical Ethics. 2009, 6 (3): 142-148.
Bazuaye G, Olayemi E: Knowledge and attitude of senior secondary school students in Benin City Nigeria to Sickle Cell Disease. World Journal of Medical Sciences. 2009, 4 (1): 46-49.
Sickle Cell Foundation Nigeria: Bringing Hope to the African Child. 2011, [cited 2012 13/12/2012]; Available from: http://www.sicklecellfoundation.com/services.php
Belsky L, Richardson HS: Medical researchers’ ancillary clinical care responsibilities. BMJ. 2004, 328 (7454): 1494-1496. 10.1136/bmj.328.7454.1494.
Kamuya D: Engaging communities to strengthen research ethics in low-income settings: selection and perceptions of members of a network in coastal Kenya. Developing World Bioethics. 2013, 3: 10-20.
Marsh V: Beginning community engagement at a busy biomedical research programme: experiences from the KEMRI CGMRC-Wellcome Trust Research Programme, Kilifi Kenya. Soc Sci Med. 2008, 67 (5): 721-733. 10.1016/j.socscimed.2008.02.007.
Emanuel EJ: What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis. 2004, 189 (5): 930-937. 10.1086/381709.
Participants at an International Workshop on Informed Consent and Community Engagement: Consent and Community Engagement in diverse research contexts: reviewing and developing research and practice. Journal of Emprical Research in Health Research Ethics. 2013, in press
Parker M: Public deliberation and private choice in genetics and reproduction. J Med Ethics. 2000, 26 (3): 160-5. 10.1136/jme.26.3.160.
Parker M: Ethical data release in genome-wide association studies in developing countries. PLoS Med. 2009, 6 (11): e1000143-10.1371/journal.pmed.1000143.
Sharp RR, Foster MW: Community Involvement in the Ethical Review of Genetic Research: Lessons from American Indian and Alaska Native Populations. Environ Health Perspect Suppl. 2002, 110 (2): 145-148. 10.1289/ehp.02110145.
Marsh VM: Experiences with community engagement and informed consent in a genetic cohort study of severe childhood diseases in Kenya. BMC Medical Ethics. 2010, 11: 13-10.1186/1472-6939-11-13.
Virtual Kenya: Virtual Kenya. 2011, Available from: http://www.virtualkenya.org/maps/map-images/422-chapter-2-spatial-patterns-of-poverty-and-human-well-being
Cowgill KD: Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA. 2006, 296 (6): 671-8. 10.1001/jama.296.6.671.
Parkin D: Sacred Void: Spatial images of work and ritual among the Giriama of Kenya. 1991, Cambridge: Cambridge University Press
Molyneux S: Benefits and payments for research participants: Experiences and views from a research centre on the Kenyan coast. BMC Medical Ethics. 2012, 13: 13-10.1186/1472-6939-13-13.
Marsh VM, Kamuya DM, Molyneux SS: 'All her children are born that way’: gendered experiences of stigma in families affected by sickle cell disorder in rural Kenya. Ethn Health. 2011, 16 (4–5): 343-59.
Molyneux CS, Peshu N, Marsh K: Understanding of informed consent in a low-income setting: three case studies from the Kenyan Coast. Soc Sci Med. 2004, 59 (12): 2547-59. 10.1016/j.socscimed.2004.03.037.
Parker M: A Deliberative Approach to Bioethics. Healthcare Ethics and Human Values. Edited by: Fulford K, Dickenson D, Murray T. 2002, Oxford: Blackwell, 29-35.
Ives J: 'Encounters with experience’: empirical bioethics and the future. Health Care Anal. 2008, 16 (1): 1-6. 10.1007/s10728-007-0077-1.
Ives J, Draper H: Appropriate methodologies for empirical bioethics: it’s all relative. Bioethics. 2009, 23 (4): 249-58. 10.1111/j.1467-8519.2009.01715.x.
Green J, Thorogood N: Qualitative methods for health research. 2007, London: SAGE Publications Ltd
Shaw A: The Contingency of the 'Genetic Link’ in Constructions of Kinship and Inheritance - An Anthropological Perspective. Freedom and Responsibility in Reproductive Choice. Edited by: Spencer J, Du Bois-Pedain A, Spencer J, Du Bois-Pedain A. 2006, Cambridge: Hart Publishing, 77-
Horstman K, Finkler K: Genetics, health care, family and kinship in a global perspective: situated processes of co-construction. Soc Sci Med. 2011, 72 (11): 1739-42. 10.1016/j.socscimed.2011.05.001.
Molyneux CS: Intra-household relations and treatment decision-making for childhood illness: a Kenyan case study. J Biosoc Sci. 2002, 34 (1): 109-31.
Featherstone K: Mutual Surveillance. Risky Relations. 2006, Oxford: Berg, 73-91.
Lindemann Nelson H, Lindemann Nelson J: The Patient in the Family: an Ethics of Medicine and Families. 1995, London: Routledge
Marsh VM: Managing misaligned paternity findings in research including sickle cell disease screening in Kenya: 'Consulting communities’ to inform policy. Soc Sci Med. 2013, 96: 192e-199.
European Society of Human, G: Genetic testing in asymptomatic minors: Recommendations of the European Society of Human Genetics. Eur J Hum Genet. 2009, 17 (6): 720-1.
Ossorio PN: Letting the gene out of the bottle: a comment on returning individual research results to participants. Am J Bioeth. 2006, 6 (6): 24-5. 10.1080/15265160600935555. author reply W10-2
Fabsitz RR: Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circulation: Cardiovascular Genetics. 2010, 3 (6): 574-80. 10.1161/CIRCGENETICS.110.958827.
Participants at the 2001 Conference on Ethical Aspects of Research in Developing Countries: Moral standards for research in developing countries: from “fair benefits” to “fair benefits”. Hastings Cent Rep. 2004, 34 (3): 17-27. 10.2307/3528416.
Widdershoven G, Abma T, Molewijk B: Empirical ethics as dialogical practice. Bioethics. 2009, 23 (4): 236-48. 10.1111/j.1467-8519.2009.01712.x.
Dunn M: Toward methodological innovation in empirical ethics research. Camb Q Healthc Ethics. 2012, 21 (4): 466-80. 10.1017/S0963180112000242.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6939/14/41/prepub